Crotalus atrox disintegrin reduces hemorrhagic transformation by attenuating matrix metalloproteinase-9 activity after middle cerebral artery occlusion in hyperglycemic male rats.

Abstract

Hemorrhagic transformation after ischemic stroke is an independent predictor for poor outcome and is characterized by blood vessel rupture leading to brain edema. To date, no therapies for preventing hemorrhagic transformation exist. Disintegrins from the venom of Crotalus atrox have targets within the coagulation cascade, including receptors on platelets. We hypothesized that disintegrins from C. atrox venom can attenuate hemorrhagic transformation by preventing activation of matrix metalloproteinase after middle cerebral artery occlusion (MCAO) in hyperglycemic rats. We subjected 48 male Sprague-Dawley rats weighing 240-260 g to MCAO and hyperglycemia to induce hemorrhagic transformation of the infarction. At reperfusion, we administered either saline (vehicle), whole C. atrox venom (two doses were used), or fractionated C. atrox venom (HPLC Fraction 2). Rats were euthanized 24 hr post-ictus for measurement of infarction and hemoglobin volume. Reversed-phase HPLC was performed to fractionate the whole venom and peaks were combined to form Fraction 2, which contained the disintegrin Crotatroxin. Fraction 2 protected against hemorrhagic transformation after MCAO, and attenuated activation of matrix metalloproteinase-9. Administering matrix metalloproteinase antagonists prevented the protection by Fraction 2. The results of this study indicate that disintegrins found in C. atrox venom may have therapeutic potential for reducing hemorrhagic transformation after ischemic stroke. Moreover, the RP-HPLC fractions retained sufficient protein activity to suggest that gentler and less efficient orthogonal chromatographic methods may be unnecessary to isolate proteins and explore their function.

• Authors: Devin W McBride, Eric C K Gren, Wayne Kelln, William K Hayes, John H Zhang
• Journal: Journal of neuroscience research (J Neurosci Res) Vol. 98 Issue 1 Pg. 191-200 (01 2020) ISSN: 1097-4547 [Electronic] United States
• PMID: 30242872 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: © 2018 Wiley Periodicals, Inc.

Chemical References

• Disintegrins
• Platelet Aggregation Inhibitors
• Matrix Metalloproteinase 9

Topics

• Animals
• Disease Models, Animal
• Disintegrins (pharmacology, therapeutic use)
• Hyperglycemia (complications, metabolism, pathology)
• Infarction, Middle Cerebral Artery (complications, drug therapy, metabolism, pathology)
• Intracranial Hemorrhages (etiology, metabolism, pathology, prevention & control)
• Male
• Matrix Metalloproteinase 9 (metabolism)
• Platelet Aggregation Inhibitors (pharmacology, therapeutic use)
• Rats
• Rats, Sprague-Dawley